These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 9045296)

  • 1. The molecular pathogenesis of treatment-induced (secondary) leukemias: foundations for treatment and prevention.
    Karp JE; Smith MA
    Semin Oncol; 1997 Feb; 24(1):103-13. PubMed ID: 9045296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The secondary leukemias: challenges and research directions.
    Smith MA; McCaffrey RP; Karp JE
    J Natl Cancer Inst; 1996 Apr; 88(7):407-18. PubMed ID: 8618232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapy-related acute leukaemia and myelodysplastic syndrome].
    Díaz Beveridge R; Aparicio Urtasun J
    An Med Interna; 2003 May; 20(5):257-68. PubMed ID: 12831302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Leukemias induced by anticancer chemotherapies].
    Harousseau JL
    Bull Cancer; 1999 Nov; 86(11):929-38. PubMed ID: 10586109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapy-related myeloid leukaemia: a model for leukemogenesis in humans.
    Larson RA; Le Beau MM
    Chem Biol Interact; 2005 May; 153-154():187-95. PubMed ID: 15935816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapy of acute myeloid leukemia: towards a patient-oriented, risk-adapted approach.
    Mandelli F; Petti MC; Lo Coco F
    Haematologica; 1998 Nov; 83(11):1015-23. PubMed ID: 9864924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is secondary leukemia an independent poor prognostic factor in acute myeloid leukemia?
    Larson RA
    Best Pract Res Clin Haematol; 2007 Mar; 20(1):29-37. PubMed ID: 17336252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do children have increased susceptibility for developing secondary acute myelogenous leukemia?
    Pyatt DW; Hays SM; Cushing CA
    Chem Biol Interact; 2005 May; 153-154():223-9. PubMed ID: 15878160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is age an independent risk factor for chemically induced acute myelogenous leukemia in children?
    Pyatt DW; Aylward LL; Hays SM
    J Toxicol Environ Health B Crit Rev; 2007; 10(5):379-400. PubMed ID: 17687725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin's disease is unlikely to be associated with a major increased risk of secondary MDS/AML.
    Harrison CN; Gregory W; Hudson GV; Devereux S; Goldstone AH; Hancock B; Winfield D; MacMillan AK; Hoskin P; Newland AC; Milligan D; Linch DC
    Br J Cancer; 1999 Oct; 81(3):476-83. PubMed ID: 10507773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment-related leukaemia--a clinical and scientific challenge.
    Ng A; Taylor GM; Eden OB
    Cancer Treat Rev; 2000 Oct; 26(5):377-91. PubMed ID: 11006138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secondary myeloid leukemia and myelodysplastic syndromes in patients treated for Hodgkin's disease: a report from the German Hodgkin's Lymphoma Study Group.
    Josting A; Wiedenmann S; Franklin J; May M; Sieber M; Wolf J; Engert A; Diehl V;
    J Clin Oncol; 2003 Sep; 21(18):3440-6. PubMed ID: 12668650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in the understanding of susceptibility to treatment-related acute myeloid leukaemia.
    Seedhouse C; Russell N
    Br J Haematol; 2007 Jun; 137(6):513-29. PubMed ID: 17539774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular evaluation of acute myeloid leukemias.
    Willman CL
    Semin Hematol; 1999 Oct; 36(4):390-400. PubMed ID: 10530720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chromosome translocations and leukemias induced by inhibitors of topoisomerase II anticarcinogenic drugs].
    Dassonneville L; Bailly C
    Bull Cancer; 1998 Mar; 85(3):254-61. PubMed ID: 9752316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Secondary leukemias: their clinical features, incidence among populations at risk, mechanisms and new strategy for prediction].
    Abe T
    Gan To Kagaku Ryoho; 1999 Nov; 26(13):1999-2008. PubMed ID: 10584563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapy-related acute myeloid leukemia after single-agent treatment with fludarabine for chronic lymphocytic leukemia.
    Lam CC; Ma ES; Kwong YL
    Am J Hematol; 2005 Aug; 79(4):288-90. PubMed ID: 16044456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predisposition to therapy-related acute leukemia with balanced chromosomal translocations does not result from a major constitutive defect in DNA double-strand break end joining.
    Coiteux V; Onclercq-Delic R; Fenaux P; Amor-Guéret M
    Leuk Res; 2007 Mar; 31(3):353-8. PubMed ID: 16890283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secondary acute leukemia following mitoxantrone-based high-dose chemotherapy for primary breast cancer patients.
    Kröger N; Damon L; Zander AR; Wandt H; Derigs G; Ferrante P; Demirer T; Rosti G; ; ;
    Bone Marrow Transplant; 2003 Dec; 32(12):1153-7. PubMed ID: 14647269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myeloid leukemia after cytotoxic therapy and other hematotoxins.
    Larson RA
    J Toxicol Environ Health A; 2000 Nov; 61(5-6):381-6. PubMed ID: 11086943
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.